IRON - Company ID 0001816736
The table below shows Disc Medicine, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$62.24M | -$41.38M | -$33.60M | -$35.47M | -$13.70M | -$15.01M |
| Capital expenditure | $0.00 | $851.00K | $67.00K | $29.00K | $100.00K | - |
| Investing cash flow | $58.31M | -$272.63M | -$67.00K | -$29.00K | -$100.00K | - |
| Dividends paid | - | - | - |
Disc Medicine, Inc. reported operating cash flow of -$180.39M for fiscal year 2025. That is down 92.1% from -$93.93M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$32.71M (FY 2020) to -$180.39M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $1.70M | $244.25M | $15.90M | $77.31M | $55.00K | $195.49M |